MinYanMD

PubMed

• 10 citations
  Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity.
  Xiaomin Zhang, Limin Cheng, Chengqi Gao, Jing Chen, Shuangye Liao, Yongqiang Zheng, Liping Xu, Jingjing He, Danyang Wang, Ziqian Fang, Jianeng Zhang, Min Yan, Yi Luan,...> ;Cancer Research. 2023 Mar 15
• 5 citations
  Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study.
  Binghe Xu, Tao Sun, Yanxia Shi, Jiuwei Cui, Yongmei Yin, Quchang Ouyang, Qiang Liu, Qingyuan Zhang, Yiding Chen, Shouman Wang, Xiaojia Wang, Zhongsheng Tong, Yahua Zho...> ;Breast Cancer Research and Treatment. 2023 Feb 1
• 57 citations
  Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-ar...
  Min Yan, Quchang Ouyang, Tao Sun, Limin Niu, Jin Yang, Li Li, Yuhua Song, Chunfang Hao, Zhanhong Chen, Armando Orlandi, Naohiro Ishii, Kazuaki Takabe, Gianluca Frances...> ;The Lancet. Oncology. 2022 Mar 1
• 1 citations
  A Case of Thrombotic Thrombocytopenic Purpura without Pathognomonic Schistocytes.
  Kevin Shengyang Yu, Min Yan> ;Clinics and Practice. 2021 Apr 13
• 10 citations
  Artificial Intelligence Treatment Decision Support For Complex Breast Cancer Among Oncologists With Varying Expertise.
  Fengrui Xu, Martín-José Sepúlveda, Zefei Jiang, Haibo Wang, Jianbin Li, Yongmei Yin, Zhenzhen Liu, M. Christopher Roebuck, Edward H. Shortliffe, Min Yan, Yuhua Song, C...> ;JCO Clinical Cancer Informatics. 2019 Aug 16
• Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial.
  Sushma S Thomas, Karen W Makar, Lin Li, Yingye Zheng, Peiying Yang, Lisa Levy, Rebecca Y Rudolph, Paul D Lampe, Min Yan, Sanford D Markowitz, Jeannette Bigler, Johanna...> ;Genomics Data. 2015 Dec 1
• 2 citations
  Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial.
  Sushma S Thomas, Karen W Makar, Lin Li, Yingye Zheng, Peiying Yang, Lisa Levy, Rebecca Yvonne Rudolph, Paul D Lampe, Min Yan, Sanford D Markowitz, Jeannette Bigler, Jo...> ;BMC Medical Genetics. 2015 Mar 24
• 23 citations
  CD20‐positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab
  Min Yan, Zhaoming Dong, Frank Zhao, Thomas Chauncey, Delva Deauna-Limayo, Jessica Wang-Rodriguez, Dayu Liu, Huan You Wang, Renate B. Pilz> ;European Journal of Haematology. 2014 Jul 1
• 40 citations
  Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis
  Sung Hee Choi, Byung-Gyu Kim, Janet Robinson, Steve Fink, Min Yan, Michael B. Sporn, Sanford D. Markowitz, John J. Letterio> ;The Journal of Clinical Investigation. 2014 Jun 2
• 6 citations
  A rare and unique case of aggressive IgE-λ plasma cell myeloma in a 28-year-old woman presented initially as an orbital mass
  Ke Li, Grace H. Ku, Min Yan, H. Elizabeth Broome, Michael J. Kelner, Huan-You Wang> ;Human Pathology. 2012 Dec 1
• 74 citations
  15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors
  Min Yan, Seung-Jae Myung, Stephen P. Fink, Earl Lawrence, James Lutterbaugh, Peiying Yang, Xiaohua Zhou, Danielle Liu, Ronald M. Rerko, Joseph Willis, Dawn M. Dawson, ...> ;Proceedings of the National Academy of Sciences of the United States of America. 2009 Jun 9
• 35 citations
  NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.
  Duncan B. Hughes, Taisuke Otani, Peiying Yang, Robert A. Newman, Rhonda K. Yantiss, Nasser K. Altorki, Jeffrey L. Port, Min Yan, Sanford D. Markowitz, Madhu Mazumdar, ...> ;Cancer Prevention Research. 2008 Sep 1
• 37 citations
  15-Hydroxyprostaglandin Dehydrogenase is a Target of Hepatocyte Nuclear Factor 3β and a Tumor Suppressor in Lung Cancer
  Guosheng Huang, Rosana Eisenberg, Min Yan, Stefano Monti, Earl Lawrence, Pingfu Fu, Jaclyn Walbroehl, Ester Löwenberg, Todd R. Golub, Jaime R. Merchan, Daniel G. Tenen...> ;Cancer Research. 2008 Jul 1
• 203 citations
  15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
  Seung-Jae Myung, Ronald M. Rerko, Min Yan, Petra Platzer, Kishore Guda, Angela Dotson, Earl Lawrence, Andrew J. Dannenberg, Alysia Kern Lovgren, Guangbin Luo, Theresa ...> ;Proceedings of the National Academy of Sciences of the United States of America. 2006 Aug 8
• 107 citations
  Recql5 and Blm RecQ DNA Helicases Have Nonredundant Roles in Suppressing Crossovers
  Yiduo Hu, Xincheng Lu, Ellen Barnes, Min Yan, Hua Lou, Guangbin Luo> ;Molecular and Cellular Biology. 2005 May 1
• 196 citations
  15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers
  Min Yan, Ronald M. Rerko, Petra Platzer, Dawn M. Dawson, Joseph Willis, Min Tong, Earl Lawrence, James Lutterbaugh, Shilong Lu, James K V Willson, Guangbin Luo, Jack O...> ;Proceedings of the National Academy of Sciences of the United States of America. 2004 Dec 14
• Join now to see all

Journal Articles

• HER2 aberrations in cancer: Implications for therapy  
  Yan M, Parker BA, Schwab R, Kurzrock R, Cancer Treat Rev, 7/1/2014
• Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis  
  Choi SH, Kim BG, Robinson J, Fink S, Yan M, Sporn MB, Markowitz SD, Letterio JJ, J Clin Invest, 6/1/2014
• CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab  
  Yan M, Dong Z, Zhao F, Chauncey T, Deauna-Limayo D, Wang-Rodriguez J, Liu D, Wang HY, Pilz R, Eur J Haematol, 2/14/2014
• A rare and unique case of aggressive IgE-lambda plasma cell myeloma in a 28-year-old woman presented initially as an orbital mass  
  Li K, Ku G, Yan M, Broome HE, Kelner M, Wang HY, Hum Pathol, 12/1/2012
• 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors  
  Yan M, Myung SJ, Fink SP, Lawrence E, Lutterbaugh J, Yang P, Zhou X, Liu D, Rerko RM, Willis J, Dawson D, Tai HH, Barnholtz-Sloan JS, Newman RA, Bertagnolli MM, Markow..., Proc Natl Acad Sci USA, 6/1/2009
• NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer  
  Hughes D, Otani T, Yang P, Newman RA, Yantiss RK, Altorki NK, Port JL, Yan M, Markowitz SD, Mazumdar M, Tai HH, Subbaramaiah K, Dannenberg AJ, Cancer Prev Res, 9/1/2008
• 15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer  
  Huang G, Eisenberg R, Yan M, Monti S, Lawrence E, Fu P, Walbroehl J, Löwenberg E, Golub T, Merchan J, Tenen DG, Markowitz SD, Halmos B, Cancer Res, 7/1/2008
• 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis  
  Yan M*, Myung SJ*, Rerko RM*, Platzer P, Guda K, Dotson A, Lawrence E, Dannenberg AJ, Lovgren AK, Luo G, Pretlow TP, Newman RA, Willis J, Dawson D, Markowitz SD. (*equ..., Proc Natl Acad Sci USA, 8/1/2006
• Recql5 and Blm RecQ DNA helicases have nonredundant roles in suppressing crossovers  
  Hu Y, Lu X, Barnes E, Yan M, Lou H, Luo G, Mol Cell Biol, 5/1/2005
• 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers  
  Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M, Lawrence E, Lutterbaugh J, Lu S, Willson JK, Luo G, Hensold J, Tai HH, Wilson K, Markowitz SD, Proc Natl Acad Sci USA, 12/1/2004
• Join now to see all

Abstracts/Posters

• HER2 distribution in diverse tumors: Analysis of 11,493 nonbreast, nongastric cancers.
  David Arguello, Sherri Z. Millis, Zoran Gatalica, Min Yan, Razelle Kurzrock, J Clin Oncol, 1/1/2014
• Prostaglandin Transporter, Down-Regulated In Colon Cancer, Mediates Prostaglandin Influx For Intracellular Degradation. Poster.
  Yan M, Markowitz S, Annual Meeting of Medical Society of the State of New York, Rochester, NY, 1/1/2009
• 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Poster.
  Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M, Lawrence E, Lutterbaugh J, Lu S, Willson JK, Luo G, Hensold J, Tai HH, Wilson K, Markowitz SD, AACR Annual Meeting, 1/1/2005

Lectures

• Invited Speaker (Distinguished Abstract Plenary), Digestive Disease Week 
  Washington Convention Center - 5/1/2007
• Invited Speaker, AACR 
  4/1/2005